Poorer outcome in stromal HIF-2 alpha- and CA9-positive colorectal adenocarcinomas is associated with wild-type TP53 but not with BNIP3 promoter hypermethylation or apoptosis.

British Journal of Cancer
A H G ClevenA P de Bruïne

Abstract

Stromal expression of hypoxia inducible factor 2 alpha (HIF-2 alpha) and carbonic anhydrase 9 (CA9) are associated with a poorer prognosis in colorectal cancer (CRC). Tumour cell death, regulated by a hypoxic stromal microenvironment, could be of importance in this respect. Therefore, we correlated apoptosis, TP53 mutational status and BNIP3 promoter hypermethylation of CRC cells with HIF-2 alpha- and CA9-related poor outcome. In a series of 195 CRCs, TP53 mutations in exons 5-8 were analysed by direct sequencing, and promoter hypermethylation of BNIP3 was determined by methylation-specific PCR. Expressions of HIF-2 alpha, CA9, p53, BNIP3 and M30 were analysed immunohistochemically. Poorer survival of HIF-2 alpha and CA9 stromal-positive CRCs was associated with wild-type TP53 (P=0.001 and P=0.0391), but not with BNIP3 methylation. Furthermore, apoptotic levels were independent of the TP53 status, but lower in unmethylated BNIP3 CRCs (P=0.004). It appears that wild-type TP53 in CRC cells favours the progression of tumours expressing markers for hypoxia in their stroma, rather than in the epithelial compartment. Preserved BNIP3 function in CRC cells lowers apoptosis, and may thus be involved in alternative cell death pathways, s...Continue Reading

References

May 1, 1988·The British Journal of Surgery·T WiggersA Volovics
Sep 3, 1996·Proceedings of the National Academy of Sciences of the United States of America·J G HermanS B Baylin
May 5, 1998·Molecular and Cellular Biology·C SchmaltzD E Fisher
Mar 18, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·U KressnerG Lindmark
May 20, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S TortolaG Capella
Jun 27, 2003·Proceedings of the National Academy of Sciences of the United States of America·Shunsuke KatoChikashi Ishioka
Sep 6, 2003·International Journal of Radiation Oncology, Biology, Physics·Corrie A M MarijnenLucy T C Peltenburg
May 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Megan M GarrityUNKNOWN North Central Cancer Treatment Group
Aug 4, 2004·Cancer Research·Jiro OkamiCraig D Logsdon
Oct 30, 2004·Annals of Medicine·Andrea L Bacon, Adrian L Harris
Dec 21, 2004·Cancer Cell·Peiwen FeiWafik S El-Deiry
Dec 30, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hiroshi YoshimuraNaofumi Nagasue
Apr 19, 2005·Cancer Research·Ioanna PapandreouNicholas C Denko
May 4, 2005·Biochemical and Biophysical Research Communications·T Soussi, G Lozano
Jul 30, 2005·International Journal of Colorectal Disease·George E TheodoropoulosDimitrios Panoussopoulos
Mar 2, 2006·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·T UenoS Linder
Apr 28, 2006·Nature·Janine T ErlerAmato J Giaccia
Jun 13, 2006·Biochemical and Biophysical Research Communications·Jin YanFu Song-bin
Nov 7, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Elza C de BruinCorrie A M Marijnen
Nov 28, 2006·Nature Reviews. Cancer·Franck Toledo, Geoffrey M Wahl
Apr 7, 2007·Cancer Metastasis Reviews·Pawel SwietachAdrian L Harris
May 8, 2007·Cell·Brian Keith, M Celeste Simon
Jun 20, 2007·Molecular and Cellular Biology·Kristin TracyKay F Macleod
Sep 7, 2007·Cancer Metastasis Reviews·Howard R Mellor, Adrian L Harris
Apr 29, 2008·Nature Medicine·Greg FinakMorag Park

❮ Previous
Next ❯

Citations

Jan 16, 2015·Cell Death & Disease·J ZhaoB Xu
Jan 15, 2014·PloS One·Mikhail PyatnitskiyEkaterina Kotelnikova

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
PCR
PCRs

Software Mentioned

Mutation Surveyor DNA Variant Analysis

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis